The Trump administration sent letters this summer to 17 makers of name-brand drugs pushing them to lower prices to align them with what other countries pay. The companies had 60 days to "step up."
Copyright 2025 NPR
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR.